What is better CXAIR Platform or PLECTO? A good way to choose the right Data Visualization Software product for your company is to match the solutions against each other. Here you can compare CXAIR Platform and PLECTO and see their capabilities compared contrastively to help you select which one is the more effective product.
Furthermore, you can review their overall ratings, including: overall score (CXAIR Platform: 8.5 vs. PLECTO: 8.2) and user satisfaction (CXAIR Platform: 97% vs. PLECTO: 90%). Check their differences and similarities and see which one outperforms the other. Similarly imagine your company tomorrow; will your business outgrow the app in the next 3-5 years?
Our team put a lot of effort to review all popular Data Analytics Software products offered on the market, but among all the ones we reviewed these three caught our special attention: Apache Spark, IBM Business Analytics, Apache Hadoop.
The product is licensed on a per-user subscription basis. There are two types:
Full users – They have complete access to full functionality, allowing them to administer the system or create and publish new analyses and reports.
Viewer users – They get a simplified interface to consume reports created and published by Full users. However, Viewer users still have all of the end-user functionality in terms of slice and dice, drill-down, etc. They have a powerful interface but just not the ability to create and publish new reports.
A typical starting deployment costs around £5,000/year which is good for 5 Full and 10 Viewer Users.
Pricing is competitive and transparent meaning there are no hidden costs which can often add to the “total cost of ownership” of the solution. In addition, the vendor offers significant discounts of up to 70% for volume purchases and attractive custom pricing for Enterprise deployments.
Where available CXAIR is able to connect to API connections and integrate with 3rd party software applications. In rare instances when development of API’s is not possible, a single CSV extract is taken and uploaded into CXAIR.
Languages Supported
English
Chinese
German
Hindi
Japanese
Spanish
French
Russian
Italian
Dutch
Portugese
Polish
Turkish
Swedish
Arabic
Prominent Clients
J.P. Morgan, Wembley, ResMed
Available Devices
Windows
Linux
Android
iPhone/iPad
Mac
Web-based
Windows Mobile
Company Size
Small Business
Large Enterprises
Medium Business
Freelancers
Available Support
email
phone
live support
training
tickets
General Info
Cloud-based or on-premise data discovery and analytics platform that helps create a single source of truth for your business. CXAIR Platform is powered by features that consolidate information regardless of structure into an organized central source. Its native data discovery functionality also makes data access and retrieval faster.
Both CXAIR Platform and PLECTO were tested by a group of independent B2B experts who conducted a full analysis of all core aspects of every software. Their final rating was calculated by means of unique SmartScore algorithm which calculates an individual partial score to each factor including: main features, customer support, mobile support, security, client satisfaction and media presence. Here at FinancesOnline we are aware that useful features are not the only thing important to a company so we make an effort to pay attention to all sides of a service before calculating its final score.
Page last modified
Why is FinancesOnline free?
FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.
